FCHS · First Choice Healthcare Solutions, Inc. · Financials
$0.01
At close · Oct 16
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If the Company is unable to secure additional capital, it may have to curtail its business development initiatives and take additional measures to reduce costs in order to conserve its cash, thus raising substantial doubt about its ability to continue as a going concern more than one year from the date of issuance of the 2025 financial statements included in this filing.”View the 10-Q filed Aug 13, 2026
Market Cap
$263,666
Shares
32.96M
Volume · Oct 16
5500
Avg daily vol (3M)
171.8K
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$1.05M
-9.6%
FY2013
Net Income
-$6.96M
-80.9%
FY2025
Operating Margin
-93.29%
-69.4pp
FY2013
Diluted EPS
-$0.21
-75%
FY2025
Operating Cash Flow
-$549.02K
+67.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.05M | — | — | — | — | — | — | — | — | $1.05M | $1.16M | $1.3M | $1.26M | |
| — | $7350 | — | $29.99K | $1.07M | — | — | — | — | — | — | — | — | |
| $5.62M | — | — | — | — | $5.59M | $5.53M | $7.14M | $2.43M | $1.75M | $1.31M | $795.73K | — | |
| $2.04M | $1.88M | $906.82K | $2.19M | $3.62M | — | — | — | $2.43M | $1.71M | $1.31M | $795.73K | $696.89K | |
| — | — | — | — | — | — | — | — | — | $20K | $15K | — | — | |
| $13.61K | $17.53K | $34.57K | $44.81K | $88.56K | $941.84K | $821.71K | $852.99K | $552.08K | $518.61K | $309.9K | $161.46K | — | |
| $2.78M | $2.68M | $1.29M | $2.44M | $8.08M | $33.15M | $29.32M | $21.45M | $9.65M | $7.12M | $4.08M | $7.63M | $896.46K | |
| -$2.78M | -$2.67M | -$1.29M | -$2.41M | -$7.02M | -$4.41M | $139.65K | -$1.93M | -$1.54M | -$978.15K | -$277.74K | -$6.32M | $366.09K | |
| — | — | — | — | — | — | — | — | — | -93.29% | -23.94% | -484.52% | 29% | |
| -$2.77M | -$2.65M | -$1.25M | -$2.37M | -$6.93M | -$3.47M | $961.36K | -$1.08M | -$991.01K | -$459.54K | $32.16K | -$6.16M | — | |
| $10.8M | $4.71M | $3.35M | $5.92M | $3.71M | — | — | — | — | $3.7M | $563.39K | -$335.39K | — | |
| -$10.59M | -$4.29M | -$2.45M | -$5.76M | -$2.93M | $20.82K | $9.13M | -$1.27M | -$946.45K | -$3.73M | -$618.73K | -$245.38K | -$300.18K | |
| -$13.37M | -$6.96M | -$3.74M | -$8.17M | -$9.94M | -$4.39M | $9.27M | -$3.2M | -$2.49M | -$4.7M | -$896.47K | -$6.57M | $65.91K | |
| — | — | $111.95K | — | — | — | — | $0 | $0 | $0 | -$23.1K | -$5916 | $29.02K | |
| -$13.37M | -$6.96M | -$3.85M | -$8.17M | -$9.94M | $3.89M | $9.17M | -$3.42M | -$2.49M | -$4.7M | -$873.36K | -$6.56M | $36.89K | |
| — | — | — | — | — | — | — | — | — | -448.68% | -75.29% | -502.87% | 2.92% | |
| -$71K | — | — | — | — | $500.87K | -$92.66K | -$217.68K | $0 | — | — | — | — | |
| -$13.47M | -$7.06M | -$3.94M | -$8.26M | -$10M | — | — | — | — | — | — | — | — | |
| USD/shares | -$0.40 | -$0.21 | -$0.12 | -$0.25 | -$0.30 | -$0.15 | $0.38 | -$0.17 | -$0.17 | -$0.35 | -$0.07 | -$0.53 | $0.00 |
| USD/shares | -$0.40 | -$0.21 | -$0.12 | -$0.25 | -$0.30 | -$0.15 | $0.37 | -$0.17 | -$0.14 | -$0.35 | -$0.07 | -$0.53 | $0.00 |
| shares | — | 32.96M | 32.96M | 32.96M | 32.96M | 26.66M | 23.84M | 20.12M | 17.25M | 13.53M | 12.64M | 12.43M | 40.06M |
| shares | — | 32.96M | 32.96M | 32.96M | 32.96M | 26.66M | 25.31M | 20.12M | 17.25M | 13.53M | 12.64M | 12.43M | 40.06M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current portion of notes payable | 2026-06-30 | USD 5,658,513 | 10-Q filed 2026-08-13 |
| Current portion of other notes payable | 2026-06-30 | USD 2,141,089 | 10-Q filed 2026-08-13 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Care Facilities median 1.43×
EV/EBIT
—
Medical Care Facilities median 18.24×
P/E (TTM)
—
Medical Care Facilities median 19.62×